B. Carneiro, R. Costa, T. Taxter, S. Chandra, Y. Chae et al., Is personalized medicine here? Oncology, pp.293-303307, 2016.

L. Wang, H. Mcleod, and R. Weinshilboum, Genomics and drug response, N Engl J Med, vol.364, pp.1144-53, 2011.

M. Duffy, C. Sturgeon, G. Sölétormos, V. Barak, R. Molina et al., Validation of New Cancer Biomarkers: A Position Statement from the European Group on Tumor Markers, Clinical Chemistry, vol.61, issue.6, pp.809-829, 2015.
DOI : 10.1373/clinchem.2015.239863

J. Jameson and D. Longo, Precision Medicine ??? Personalized, Problematic, and Promising, New England Journal of Medicine, vol.372, issue.23, pp.2229-2263, 2015.
DOI : 10.1056/NEJMsb1503104

U. Mcdermott, J. Downing, and M. Stratton, Genomics and the continuum of cancer care, N Engl J Med, vol.364, pp.340-50, 2011.

S. Waldman and A. Terzic, Clinical and Translational Science: From Bench-Bedside to Global Village, Clinical and Translational Science, vol.304, issue.5, pp.254-261, 2010.
DOI : 10.1111/j.1752-8062.2010.00227.x
URL : http://doi.org/10.1111/j.1752-8062.2010.00227.x

S. Hostiuc, A. Moldoveanu, M. Dasc?lu, R. Unnthorsson, Ó. Jóhannesson et al., Translational research???the need of a new bioethics approach, Journal of Translational Medicine, vol.78, issue.4, p.16, 2016.
DOI : 10.1186/s12967-016-0773-4

S. Artene, M. Ciurea, S. Purcaru, D. Tache, L. Tataranu et al., Biobanking in a Constantly Developing Medical World, The Scientific World Journal, vol.343, issue.3, p.343275, 2013.
DOI : 10.1183/09031936.00165006
URL : http://doi.org/10.1155/2013/343275

L. Siu, M. Lawler, D. Haussler, B. Knoppers, J. Lewin et al., Facilitating a culture of responsible and effective sharing of cancer genome data, Nature Medicine, vol.60, issue.5, pp.464-71, 2016.
DOI : 10.1016/j.ejca.2014.07.025

M. Kagarise and G. Sheldon, Translational Ethics, Archives of Surgery, vol.135, issue.1, pp.39-45, 2000.
DOI : 10.1001/archsurg.135.1.39

S. Wolf, W. Burke, and B. Koenig, Mapping the ethics of translational genom? ics: situating return of results and navigating the research?clinical divide, J Law Med Ethics, vol.43, pp.486-501, 2015.

A. Cribb, Translational ethics? The theory-practice gap in medical ethics, Journal of Medical Ethics, vol.36, issue.4, pp.207-217, 2010.
DOI : 10.1136/jme.2009.029785

D. Nicol, T. Bubela, D. Chalmers, J. Charbonneau, C. Critchley et al., Precision medicine: drowning in a regulatory soup?, Journal of Law and the Biosciences, vol.3, issue.2, pp.281-303, 2016.
DOI : 10.1093/jlb/lsw018
URL : http://doi.org/10.1093/jlb/lsw018

Y. Joly, K. Saulnier, G. Osien, and B. Knoppers, The ethical framing of personalized medicine, Current Opinion in Allergy and Clinical Immunology, vol.14, issue.5, pp.404-412, 2014.
DOI : 10.1097/ACI.0000000000000091

B. Rance, V. Canuel, H. Countouris, P. Laurent?puig, and A. Burgun, Integrating Heterogeneous Biomedical Data for Cancer Research: the CARPEM infrastructure, Applied Clinical Informatics, vol.7, issue.2, pp.260-74, 2016.
DOI : 10.4338/ACI-2015-09-RA-0125

J. Taieb, A. Zaanan, L. Malicot, K. Julié, C. Blons et al., Prognostic effect of BRAF and KRAS mutations in patients with stage III colon cancer treated with leucovorin, fluorouracil, and oxaliplatin with or without cetuximab: a post hoc analysis of the PETACC?8 trial, JAMA Oncol, vol.2, pp.1-11, 2016.

E. Becht, A. De-reyniès, N. Giraldo, C. Pilati, B. Buttard et al., Immune and Stromal Classification of Colorectal Cancer Is Associated with Molecular Subtypes and Relevant for Precision Immunotherapy, Clinical Cancer Research, vol.22, issue.16, pp.4057-66, 2016.
DOI : 10.1158/1078-0432.CCR-15-2879

J. Mccormick, R. Sharp, A. Ottenberg, C. Reider, H. Taylor et al., The Establishment of Research Ethics Consultation Services (RECS): An Emerging Research Resource, Clinical and Translational Science, vol.311, issue.1, pp.40-44, 2013.
DOI : 10.1111/cts.12008

R. Sharp, H. Taylor, M. Brinich, M. Boyle, M. Cho et al., Research Ethics Consultation, Academic Medicine, vol.90, issue.5, pp.615-635, 2015.
DOI : 10.1097/ACM.0000000000000640
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414686

V. Canuel, B. Rance, P. Avillach, P. Degoulet, and A. Burgun, Translational research platforms integrating clinical and omics data: a review of publicly available solutions, Briefings in Bioinformatics, vol.16, issue.2, pp.280-90, 2015.
DOI : 10.1093/bib/bbu006

A. Burgun, A. Jannot, B. Rance, and M. Mamzer, Sharing patient data for research: organizational and ethical aspects, JEMEP, vol.2, issue.3, pp.435-476, 2016.

P. Marvanne, C. Rambaud, and C. Vergely, La médecine prédictive ou person? nalisée: prévoir les conséquences médicales, sociales et sociétales In: Les nouveaux paradigmes de la médecine personnalisée ou médecine de précision, pp.201-211, 2014.

Z. Master, E. Nelson, B. Murdoch, and T. Caulfield, Biobanks, consent and claims of consensus, Nature Methods, vol.140, issue.9, pp.885-893, 2012.
DOI : 10.1097/GIM.0b013e31821d2f88

M. Hansson, J. Dillner, C. Bartram, J. Carlson, and G. Helgesson, Should donors be allowed to give broad consent to future biobank research?, The Lancet Oncology, vol.7, issue.3, pp.266-275, 2006.
DOI : 10.1016/S1470-2045(06)70618-0

P. Leroy, M. Mamzer?bruneel, C. Hervé, and F. Scotté, Une étude des conditions de recueil des consentements : quels enseignements ? In: Les nouveaux paradigmes de la médecine personnalisée ou médecine de précision. Paris: Dalloz Ed, pp.179-84, 2014.

A. Hoos, J. Anderson, M. Boutin, L. Dewulf, J. Geissler et al., Partnering With Patients in the Development and Lifecycle of Medicines, Therapeutic Innovation & Regulatory Science, vol.9, issue.6, pp.929-968, 2015.
DOI : 10.1200/EdBook_AM.2013.33.e126

D. Butler, Translational research: Crossing the valley of death, Nature, vol.453, issue.7197, pp.840-842, 2008.
DOI : 10.1038/453840a

E. Collins, Publishing priorities of biomedical research funders, BMJ Open, vol.3, p.4171, 2013.

C. Petrini, Ethical Issues in Translational Research, Perspectives in Biology and Medicine, vol.53, issue.4, pp.517-550, 2010.
DOI : 10.1353/pbm.2010.0007

I. Budin?ljøsne and J. Harris, Patient and interest organizations??? views on personalized medicine: a qualitative study, BMC Medical Ethics, vol.14, issue.7272, p.28, 2016.
DOI : 10.1186/s12910-016-0111-7